05-Nov-2026 22:23:39
JUBLPHARMA : RAISES RS 800 CR VIA NCD PRIVATE PLACEMENT
• Finance Committee approved allotment of 80,000 unsecured, rated, listed, redeemable NCDs of face value ₹1,00,000 each at par • Issue aggregates to ₹800 Cr on…
Latest market headlines for JUBLPHARMA on Terminal.
05-Nov-2026 22:23:39
• Finance Committee approved allotment of 80,000 unsecured, rated, listed, redeemable NCDs of face value ₹1,00,000 each at par • Issue aggregates to ₹800 Cr on…
14-Oct-2026 16:32:10
Icra assigned [ICRA]AA+ (Stable) rating to the company's proposed non-convertible debentures of ₹1,400 Cr, per its letter dated October 13, 2026.
12-Oct-2026 19:34:19
QUANT MUTUAL FUND, 11,00,000 SHARES SOLD 🔴 ... ABAKKUS FOUR2EIGHT OPPORTUNITIES FUND, 11,00,000 SHARES BOUGHT 🟢
12-Oct-2026 12:36:47
• Board approved issuance of up to 80,000 NCDs of face value ₹1 L each, aggregating up to ₹800 Cr on private placement basis • NCDs are secured / unsecured, li…
07-Oct-2026 19:45:16
JUBILANT PHARMA : RAISES FUNDS VIA NCDs
28-Sept-2026 18:47:19
• Specimen of intimation sent to security holders whose final dividend for FY 2025-26 has been withheld due to non-submission of KYC documents. • Information a…
11-Sept-2026 19:44:44
• USFDA has concluded its review of the Establishment Inspection Report (EIR) for the inspection conducted at Jubilant HollisterStier LLC's CMO facility in Spo…
23-Aug-2026 00:50:40
• Jubilant HollisterStier LLC, a subsidiary of Jubilant Pharma Holding Inc., has received USFDA approval for commercial batch manufacturing on Line 3 at its Sp…
16-Jul-2026 18:30:04
• Company received rectification order from Income Tax Department on July 15, 2026, for AY 2020-21. • The order deletes the impugned tax demand of Rs. 22.10 cr…